Meghji Mohsin Y, Executive Chairman of the Board, sold M3-Brigade Acquisition V Corp. ($MBAV) shares on the open market once in the last year for a total of $0.00. His most recent sale occurred on May 27, 2025. These MBAV insider sales rank 11,670th out of 11,678 individuals in our database by amount sold, well below the average of $8.6 million across 6 transactions per insider. Meghji Mohsin Y reported no open market purchases of MBAV shares in the past 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | M3-Brigade Acquisition V Corp. | $MBAV | Meghji Mohsin Y | Executive Chairman of BOD | S | Class B ordinary shares | 7187500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 1, 2023 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | A | Common Stock | 11867 | $1.58 | 109,737.0000 | 0 | 12.13% | 0.00% |
| Jan. 1, 2023 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | A | Common Stock | 8227 | $2.28 | 77,705.0000 | 0 | 11.84% | 0.00% |
| April 15, 2023 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | A | Common Stock | 9920 | $1.89 | 87,625.0000 | 0 | 12.77% | 0.00% |
| July 1, 2023 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | A | Common Stock | 10245 | $1.83 | 97,870.0000 | 0 | 11.69% | 0.00% |
| Sept. 6, 2022 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | C | Common Stock, par value $0.007 | 40907 | $3.67 | 69,478.0000 | 0 | 143.18% | 0.00% |
| Sept. 6, 2022 | bioAffinity Technologies, Inc. | $BIAF | Meghji Mohsin Y | Director | C | Series A Convertible Preferred Stock | 286349 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |